Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

FFA and FAPD might be related or stages of the same disease.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Long hair can cause hair loss in the middle of the scalp, and cutting it shorter helps.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

FFA has higher long-term remission rates than LPP.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.